EGM
VTVT icon

Engineers Gate Manager’s vTv Therapeutics VTVT Stock Holding History

Engineers Gate Manager’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-390
Closed -$12K – 2107
2022
Q2 		$12K Sell
390
-3
-0.8% -$77 ﹤0.01% 1840
2022
Q1 		$11K Hold
393
– – ﹤0.01% 1785
2021
Q4 		$16K Sell
393
-2
-0.5% -$107 ﹤0.01% 1947
2021
Q3 		$24K Sell
395
-236
-37% -$17.8K ﹤0.01% 1584
2021
Q2 		$58K Sell
631
-210
-25% -$21.3K ﹤0.01% 1541
2021
Q1 		$95K Sell
841
-27
-3% -$2.65K ﹤0.01% 1711
2020
Q4 		$65K Buy
+868
New +$66.6K ﹤0.01% 1621

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Engineers Gate Manager's VTVT Position: Q3 2022 in Review

Engineers Gate Manager sold out of vTv Therapeutics (VTVT) in Q3 2022, closing a stake of 390 shares — an estimated $12K sold.

Engineers Gate Manager first reported a position in VTVT in Q4 2020 and held it in 7 quarters. The position peaked at $95K in Q1 2021. 27 funds tracked by Wall St. Rank hold VTVT as of Q3 2022.

  • Engineers Gate Manager reported no remaining vTv Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 390 vTv Therapeutics shares in Q3 2022, an estimated $12K.
  • Engineers Gate Manager first reported a position in vTv Therapeutics in Q4 2020 and held it in 7 quarters.
  • Engineers Gate Manager's vTv Therapeutics position peaked at $95K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2022.

Based on Engineers Gate Manager's 13F filing for Q3 2022, filed 14 Nov 2022.